Embecta Corp (EMBC)
Return on equity (ROE)
| Sep 30, 2023 | Sep 30, 2022 | ||
|---|---|---|---|
| Net income | US$ in thousands | 70,400 | 223,600 |
| Total stockholders’ equity | US$ in thousands | -821,700 | -891,400 |
| ROE | — | — |
September 30, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $70,400K ÷ $-821,700K
= —
Peer comparison
Sep 30, 2023
Company name
Symbol
ROE
Embecta Corp
EMBC
—
3M Company
MMM
-145.52%
Artivion Inc
AORT
-10.89%
Baxter International Inc
BAX
31.61%
Becton Dickinson and Company
BDX
5.75%
Boston Scientific Corp
BSX
8.25%
DexCom Inc
DXCM
26.18%
Glaukos Corp
GKOS
-29.16%
Globus Medical
GMED
3.07%
Haemonetics Corporation
HAE
12.25%
ICU Medical Inc
ICUI
-1.40%